THE PRESENCE OF BCL-1 AND BCL-2 GENE REARRANGEMENTS IN DIFFUSE SMALL CLEAVED-CELL LYMPHOMA - A DISEASE WITH DIVERSE MOLECULAR AND IMMUNOPHENOTYPIC FINDINGS

Citation
Cp. Leith et al., THE PRESENCE OF BCL-1 AND BCL-2 GENE REARRANGEMENTS IN DIFFUSE SMALL CLEAVED-CELL LYMPHOMA - A DISEASE WITH DIVERSE MOLECULAR AND IMMUNOPHENOTYPIC FINDINGS, Diagnostic molecular pathology, 3(3), 1994, pp. 178-183
Citations number
43
Categorie Soggetti
Pathology
ISSN journal
10529551
Volume
3
Issue
3
Year of publication
1994
Pages
178 - 183
Database
ISI
SICI code
1052-9551(1994)3:3<178:TPOBAB>2.0.ZU;2-S
Abstract
Clonal rearrangements of the bcl-1 and bcl-2 protooncogenes are found in many B-lineage non-Hodgkin's lymphomas (NHL) and may play a role in their pathogenesis. We investigated rearrangements of the bcl-1 and b cl-2 protooncogenes in 13 cases of B lineage diffuse small cleaved-cel l lymphoma (DSCL), and correlated the results with clinical history, i mmunophenotype, and outcome. Six cases showed bcl-2 rearrangements, in cluding four patients with an antecedent follicular small cleaved-cell lymphoma (FSCL). Two patients had a bcl-1 rearrangement, including on e with a previous FSCL. Of the five patients who lacked detectable bcl -1 or bcl-2 rearrangements, one had an FSCL history. Similar to the la ck of correlation between clinical history and genotype, there was no correlation between genotype and immunophenotype. Our results indicate that although DSCL is a morphologically uniform disease, different mo lecular genetic pathways are involved in its genesis. Follow-up showed four of the six DSCL patients with bcl-2 rearrangements were alive wi th a median survival of 56 months, whereas the median survival of the seven patients lacking a bcl-2 rearrangement was 17 months and include d only one survivor. Thus bcl-2 rearrangements in DSCL may define a pa tient subset with a more indolent genetic abnormality and prolonged su rvival.